Peptic Ulcer Hemorrhage
26
0
0
18
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
11.5%
3 terminated out of 26 trials
85.7%
-0.8% vs benchmark
42%
11 trials in Phase 3/4
11%
2 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (26)
Anticoagulation With Enhanced Gastrointestinal Safety
Diagnostic Performance of CIM for Helicobacter Pylori Infection in Patients With Peptic Ulcer Bleeding
Precise Delivery of Tranexamic Acid to Enhance Endoscopic Hemostasis for Peptic Ulcer Bleeding
The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
Registry for Upper Gastrointestinal Bleeding
Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
ClearEndoclip Versus EZ Clip for Upper Gastrointestinal Ulcer Bleeding
Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients
Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment
Supplementary Angiographic Embolization for Peptic Ulcer Bleeding
Resolution Endoclips Vs Epinephrine Injection and Heater Probe
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage
China Survey of Peptic Ulcer Bleeding
The Dissemination of Consensus Recommendations on Upper Gastrointestinal Bleeding